-
Successful Test of AI and Molecular Twin Platform May Lead to Greater Accuracy in Mesothelioma Prognosis
Results from a Cedars-Sinai Cancer Center study suggest that artificial intelligence and precision medicine may soon lead to greater accuracy in survival predictions for malignant pleural mesothelioma. The research, published in Nature Cancer, details how scientists were able to use the technology to identify biomarkers that were superior to the tests currently in use.
-
Hess to Pay $187 Million in Mesothelioma and Asbestos Settlement
A notice of settlement has been filed by oil and gas company Hess Corporation, ending years of litigation filed by mesothelioma and other asbestos-related disease victims on the island of St. Croix. The company’s payment relates to negligence claims against its bankrupt unit HONX, which operated a refinery on the island from 1965 to 1998.
-
Mesothelioma Victim’s Family Reaches Settlement with Prominent Aerospace Companies
Malignant mesothelioma deaths lead to grief and financial hardship. The painful loss of loved ones and insurmountable medical bills lead many families to file lawsuits against the companies that are responsible. While some do battle for years, others allow their mesothelioma attorneys to settle their claims out of court so they can be compensated for
-
Seaman Files Asbestos Claim Against Shipping Company
After years of working as a commercial fisherman on ships he’d been told were contaminated with asbestos, Riccardo Ciolino began experiencing symptoms that he feared signaled mesothelioma. His doctors diagnosed him with a different disease that is also caused by exposure to asbestos, and he filed a claim against his former employer. Facing accusations of
-
Mesothelioma Vaccine Given Fast Track Status by FDA
The U.S. Food and Drug Administration has given fast-track designation to a promising new cancer vaccine used with nivolumab (Opdivo) and ipilimumab (Yervoy) in treating unresectable malignant pleural mesothelioma. The approval follows a recently completed phase 2 clinical trial that offered promising results.
-
Navy Veteran Describes “Dirty Work” in Mesothelioma Claim
It is a tragic but true fact that America’s service branches made frequent use of asbestos for decades, and as a result, a significant portion of mesothelioma victims in the United States are veterans. Asbestos companies are frequently named in personal injury lawsuits seeking compensation for the harm that veterans have suffered. In a recent case,
-
First Patient Dosed in Phase 2 Clinical Study of Drug for Pleural Mesothelioma
Biotechnology company RS Oncology has announced the start of a new Phase 2 clinical study of its drug, RSO-021 for the treatment of malignant pleural mesothelioma and other thoracic malignancies, and the successful first dosing of a patient. The multicenter study based in the United Kingdom is evaluating the drug’s impact on patients suffering the
-
J&J’s Attorneys Question Ovarian Cancer Talc Victims’ Reliance on Mesothelioma Study
Johnson & Johnson is currently facing over 40,000 personal injury claims blaming its talc for cases of ovarian cancer and malignant pleural mesothelioma. At issue is whether the product causes these illnesses and whether the company was aware of its dangers. As multidistrict litigation exclusively filed by ovarian cancer victims is set to begin in
-
Novel Defense in Asbestos Lung Cancer Lawsuit Defeated
In 2019, Francesco Carboni died of asbestos-related lung cancer. His widow, Susan, blamed the asbestos he was exposed to as a result of his work as an auto mechanic for his exposure and blamed multiple companies. Included among them was a company operating as Alfa Romeo USA. After years of participating in the litigation, the
-
Welder’s Mesothelioma Blamed on Asbestos in Safety Gloves
Mario Caligiuri blames his mesothelioma diagnosis on the asbestos he was exposed to during his career as a welder. When filed a personal injury lawsuit against companies whose asbestos-contaminated products he used or was exposed to, he included Olympic Glove & Safety Co., Inc. whose gloves he wore in the 1970s. Olympic filed a motion
-
Colgate Palmolive’s Attempt to Dismiss Mesothelioma Claim Called “Substantively Defective”
Last October, Paula Corin filed a personal injury claim against forty-three different companies, blaming them for exposing her to the asbestos that caused her malignant pleural mesothelioma. Her suit was filed in the Los Angeles County Superior Court, and the day after she filed, Colgate-Palmolive removed the case to the U.S. District Court on the
-
Study Reveals Benefit of Combining Pembrolizumab with Chemotherapy for Pleural Mesothelioma
Immunotherapy treatment has become one of the greatest sources of optimism for patients with cancers of all types, including mesothelioma. A group of international researchers recently released the findings of their study investigating combining one immunotherapy drug, pembrolizumab, with the gold standard chemotherapy treatment for the rare asbestos-related disease and found that it significantly improved patients’
-
Second-Hand Asbestos Exposure Blamed for Woman’s Mesothelioma Death
Roseanna Matherne died of malignant pleural mesothelioma after years of laundering her husband’s asbestos-contaminated work clothes. Her family blamed the Avondale Shipyard for failing to warn and failure to implement appropriate safety measures that would have prevented her secondary exposure. When the company tried to advance a government contractor defense, Mrs. Matherne’s family moved for partial
-
Asbestos Companies’ Legal Strategy in Mesothelioma Claims Spurs Action from Senators
Mesothelioma victims and others exposed to asbestos are well aware that some of the country’s biggest and most successful companies, including Georgia-Pacific and Johnson & Johnson have turned to a questionable legal strategy to evade liability for their negligence. In the face of thousands of victims being prevented from seeking justice, three U.S. senators and
-
Insurance Company’s Attempt to Shut Down Mesothelioma Claim Fails
When a mesothelioma victim or their family member decides to file a personal injury lawsuit against those they blame for their illness, the claim can include all parties involved, from the mine where the asbestos originated to the manufacturer and sellers of the asbestos-contaminated products and their insurance companies. These companies frequently use multiple legal
-
Japanese Physicians Warn Against First Line Nivolumab Plus Ipilimumab in Elderly Mesothelioma Patients
Malignant mesothelioma is a rare and deadly form of cancer most frequently diagnosed decades after its victims are exposed to asbestos. The long latency means that the median age at diagnosis is 76 years old. Though immunotherapy treatment of nivolumab plus ipilimumab has provided superior survival outcomes as a first-line treatment for the disease, Japanese
-
Portugal Hospital Reports Complete Response to Immunotherapy for Peritoneal Mesothelioma Patient
This morning, an article appeared in a respected medical journal reporting on a complete response to the immunotherapy drug pembrolizumab in a patient with malignant peritoneal mesothelioma. The case study’s authors encourage the drug’s use, despite the lack of evidence to support the treatment.
-
Oregon Mesothelioma Victim’s Survivors Succeed in Returning Claim to State Court
When Elsie Louise Graham died of malignant mesothelioma, her family filed suit against numerous defendants they accused of exposing her to asbestos through the talcum powder products, including the owner of a local market where she had purchased the powders. In response, the consumer giants named in the case argued that the case should be
-
New Construction Industry Study Reveals Mesothelioma Risk from Aging Asbestos Water Pipes
A new report released by Occupational Knowledge International confirmed what mesothelioma experts and advocates have long known: construction workers face ongoing risk from asbestos concrete products, particularly from aging asbestos concrete water pipes.
-
Mesothelioma Verdict Overturned Based on Court’s Abuse of Discretion
The family of a man who died of malignant mesothelioma in 2012 will have another chance at justice after an appeals court agreed that the trial court hearing their original claim abused its discretion in ruling that an elderly witness had to testify in person. The Appellate Court of Illinois ruled that refusing the witness
